Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of L-carnitine and extracts of ginkgo biloba
AssigneeSigma-Tau HealthScience S.p.A.
InventorClaudio Cavazza
Life of this patent
Estimating the term…
Abstract
A composition is disclosed suitable for the prevention and/or treatment of circulatory disorders at both peripheral and cerebral level, and which can therefore take the form of a dietary supplement, a dietetic support or of an actual medicine, comprising as characterizing active ingredients: (a) a carnitine selected from the group consisting of acetyl L-carnitine and propionyl L-carnitine or a pharmacologically acceptable salt thereof or mixtures thereof; and (b) an extract of Ginkgo biloba or one or more of the ginkgolides isolated from Ginkgo biloba or mixtures thereof.
Claims18
A combination composition comprising as characterising active ingredients:
- (a) a mixture of L-carnitine (LC), acetyl L-carnitine (ALC) and propionyl L-carnitine (PLC) or of the pharmacologically acceptable salts thereof;
- and
- (b) an extract of Ginkgo biloba or one or more ginkgolides isolated therefrom or mixtures thereof.
A therapeutic method for the treatment of peripheral or central circulatory insufficiency at the myocardial, cerebral, peripheral vascular level or of coronary disorders, nervous depressions, insomnia, fatigue, intermittent claudication, tinnitus, or penile erectile disorders, of both vascular and metabolic cerebral function deficiencies, and of articular or gastric inflammatory reactions, which comprises administering to a subject a combination composition comprising the following ingredients:
- (a) a mixture of L-carnitine (LC), acetyl L-carnitine (ALC) and propionyl L-carnitine (PLC) or of the pharmacologically acceptable salts thereof;
- and
- (b) an extract of Ginkgo biloba or one or more ginkgolides isolated therefrom or mixtures thereof.
Dependencies are inferred from the claim text.